Matches in DBpedia 2014 for { ?s ?p Medpace is a Contract Research Organization (CRO).CROs are clinical research partners for drug developers in the pharmaceutical and biotech industries - conducting clinical trials that are required by the U.S. Food and Drug Administration (FDA) and other global regulatory organizations before drugs and medical devices are approved for human use. CROs were developed in the late 70s as a response to pharmaceutical companies’ needs for outsourcing partners to handle larger and more complex clinical studies, and reduce fixed costs of drug developers.Medpace provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services. Medpace conducts studies in approximately 40 countries and employs approximately 1,400 people in 19 global offices. Medpace is considered a mid size CRO.In February 2014, Medpace was sold to private equity firm Cinven by CCMP Capital for around $900 million.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Medpace abstract "Medpace is a Contract Research Organization (CRO).CROs are clinical research partners for drug developers in the pharmaceutical and biotech industries - conducting clinical trials that are required by the U.S. Food and Drug Administration (FDA) and other global regulatory organizations before drugs and medical devices are approved for human use. CROs were developed in the late 70s as a response to pharmaceutical companies’ needs for outsourcing partners to handle larger and more complex clinical studies, and reduce fixed costs of drug developers.Medpace provides services for Phase I-IV of drug and medical device development services including regulatory services and central laboratory services. Medpace conducts studies in approximately 40 countries and employs approximately 1,400 people in 19 global offices. Medpace is considered a mid size CRO.In February 2014, Medpace was sold to private equity firm Cinven by CCMP Capital for around $900 million.".